Nuo Therapeutics, Inc.
Symbol: AURX
PNK
0.8
USDMarktpreis heute
-10.7721
P/E-Verhältnis
-0.1077
PEG-Verhältnis
35.39M
MRK Kapital
- 0.00%
DIV Rendite
Nuo Therapeutics, Inc. (AURX) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.9 | 2.1 | 0.1 | |||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 0.3 | 0.1 | 0 | |||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 0.2 | 0.2 | 0 | |||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 0.2 | 0.2 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 1.6 | 2.6 | 0.1 | |||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0.3 | 0.4 | 0 | |||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 0.3 | 0.4 | 0 | |||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1.9 | 3 | 0.1 | |||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 0.4 | 0.4 | 0.5 | |||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 0.1 | 0 | |||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0.2 | 0.3 | 0 | |||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 0.3 | 0.1 | 0.1 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0.2 | 0.3 | 0 | |||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.2 | 0.3 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 0.8 | 0.9 | 0.7 | |||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -29.9 | -26.8 | -23.5 | |||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 31 | 29 | 23 | |||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1 | 2.2 | -0.5 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1.9 | 3 | 0.1 | |||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1 | 2.2 | -0.5 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 0.3 | 0.3 | 0 | |||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -0.7 | -1.7 | -0.1 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -3.2 | -3.2 | 0 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.1 | 0.1 | 0 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 13936 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -0.3 | -0.5 | 0 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -0.3 | -0.1 | 0 | |||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | -0.2 | 0 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -0.2 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 0.2 | -0.1 | -13936 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -0.1 | 0 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2 | 4.5 | 1.4 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 2 | 4.5 | 1373092 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2 | 4.5 | 1373092 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -1.2 | 0.7 | 0 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 0.9 | 2.1 | 0.1 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2.1 | 1.4 | 0.2 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -3.2 | -3.7 | 0 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -3.2 | -3.8 | 0 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0.6 | 0.1 | 0 | |||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0.1 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 0.5 | 0.1 | 0 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 3.7 | 3.4 | 0.1 | |||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3.8 | 3.4 | 0.1 | |||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | -48390 | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0 | 0.1 | 287189 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0 | 0.1 | 287189 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | -48390 | |||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -3.2 | -3.3 | -0.1 | |||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -3.2 | -3.2 | -0.1 | |||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | -0.1 | 287188.9 | |||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -3.2 | -3 | -0.1 |
Häufig gestellte Frage
Wie hoch ist die Nuo Therapeutics, Inc. (AURX) Gesamtvermögen?
Nuo Therapeutics, Inc. (AURX) Gesamtvermögen ist 1877880.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.793.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.074.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -5.214.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -5.206.
Was ist der Nuo Therapeutics, Inc. (AURX) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -3171436.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 255592.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 3650707.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.